3rd International Medical Cannabis Conference (CannX 2018)
Tel Aviv, Israël, October 14–16, 2018
Medical Cannabis and Cannabinoids, 2018, 1, 119–129
Published online : October 4, 2018
DOI: 10.1159/000493905
Abstracts
CANNX18-0023
Co-Culture, Stigma and Deprivations among Medical Cannabis Patients in Israel
H. Bonny-Noach
Ariel University, Department of Criminology, Ariel, Israel
CANNX18-0039
Cannabis Is Personal: The Intersection Between Human Genetics and Cannabis
L. May, CEO & Founder of EndoCanna Health, Seattle, USA
CANNX18-0046
Rationale to Evaluate Community-Led Interventions Employing Cannabis as Harm Reduction During the Opioid Overdose Crisis
M.J. Milloy1, K. Heed2
1British Columbia Centre on Substance Use, Research, Vancouver, Canada; 2GrowX Global, Operations, Vancouver- BC, Canada
CANNX18-0041
Concrete Evidence of Medical Cannabis Saving Lives and How Data Can Help the Cause
C. Moore1
1Phillip Millar is the CEO of Medical Marijuana Consulting MMC, Phillip is CEO- Contact person is Director of Marketing, London, Canada
CANNX18-0037
Clinical Trials: The Santé Cannabis Model
E. Prosk1, A. Vigano2
1Santé Cannabis, Research, Montreal, Canada;
2McGill Univerity, Oncology, Montreal, Canada
CANNX18-0032
Knowledge and Attitudes About Cannabis Among Mental Health Clinicians
J. Roberts1,2, J. Marcu1
1International Research Center on Cannabis and Mental Health, Translational Research, New York, USA; 2New York University, Silver School, New York, USA
CANNX18-0034
Medical Cannabis Oil: Results from the First-in-Human Phase 1, Double-Blind, Randomized, Placebo-Controlled Study
M.F. Arboleda1,2, E. Prosk2, G. Chamberland3, A. Vigano1,2
1McGill University Health Center, Oncology- Supportive and Palliative Care Division, Montreal, Canada; 2Santé Cannabis, Research, Montreal, Canada; 3Tetra Bio-Pharma, Research, Montreal, Canada
CANNX18-0045
Frequent Cannabis Use Associated with Lower Risk of Non-Fatal Overdose in a Setting with a Community-Wide Opioid Overdose Crisis
M.J. Milloy, S. Lake, E. Socias, K. Hayashi, K. DeBeck, E. Wood
British Columbia Centre on Substance Use, Research, Vancouver, Canada
CANNX18-0038
PTSD & Insomnia: Polysomnographic Evidence of Changes in Sleep Architecture and Sleep/Wake Functioning with Medical Cannabis Treatment
D. Miri1, A. Donath2, C. Thirlwell1
1Sleep Wake Awareness Program SWAP, Psychiatrist & Sleep Medicine, Toronto, Canada; 2Tilray, Clinical Relations Manager, Toronto, Canada
CANNX18-0035
Cannabis Use as an Alternative for Opioids, Antipsychotics and Antidepressants Among Geriatric Patients in a Long-Term Care Setting : A Case Series
B. Pearson
Greenly Health Ltd., Medical Research, Sarnia- Ontario, Canada
CANNX18-0028
A New Formulation of Cannabidiol and Chitosan for the Treatment of Dyslipidemia and Weight Gain
D. Robinson1, S. Prutchi Sagiv2, N. Ben Shalom3
1 Rabin Medical Center, Orthopedics, Petach Tikvah, Israel;
2 CannaLean, R&D, Bnei Brak, Israel; 3CannaLean, Chemistry, Bnei Brak, Israel
CANNX18-0040
Heavy Recreational Cannabis Use Negatively Impacts on Bone Health – A Cross-Sectional Study
A. Sophocleous1,2, R. Robertson3,4, N. B. Ferreira5, J. McKenzie2,4,
W.D. Fraser6, S.H. Ralston2
1 European University Cyprus, Department of Life Sciences- School of Sciences, Nicosia, Cyprus; 2 University of Edinburgh, Rheumatology and Bone Diseases Unit- Centre for Genomic and Experimental Medicine- MRC Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom; 3 University of Edinburgh, Usher Institute of Population Health Sciences and Informatics, Edinburgh, United Kingdom; 4 National Health Service, Muirhouse Medical Group, Edinburgh, United Kingdom;
5 University of Nicosia, Department of Social Sciences- School of Humanities and Social Sciences, Nicosia, Cyprus; 6University of East Anglia, Department of Medicine, Norwich, United Kingdom
CANNX18-0024
Fungi Get “High” with the Synthetic Cannabinoid HU-210?
D. Steinberg1, R. Smoun2, R. Mechoulam2, M. Feldman1
1 Hebrew University, Biofilm Research Laboratory, Jerusalem,
Israel; 2 Hebrew University, Pharmacy, Jerusalem, Israel
CANNX18-0033
New Frontiers in Treating Chronic Insomnia in Canadian Veterans with PTSD: Retrospective Analysis Reveals an Innovative Role for Medical Cannabis in Optimizing Sleep/Wake Health
C. Thirlwell1, K. Rainville2, D. Miri1, A. Donath3, H. Shulman4
1 Sleep Wake Awareness Program SWAP, Psychiatry & Sleep Medicine, Toronto, Canada; 2 Canna Connect, Cannabis Educator & Veteran Advocate, Ste Emelie de L’Energie, Canada; 3 Tilray, Clinical Relations Manager, Toronto, Canada; 4 Sleep Wake Awareness Program SWAP, Research and Statistical Analysis, Toronto, Canada
CANNX18-0044
The Effects of Cannabis Use on Cardiac Rate and Rhythm in Post-Myocardial Infarction Subjects
C. Tompkins, L. Walker
University of Colorado Anschutz Medical Campus, Medicine/ Cardiology, Aurora CO, USA
CANNX18-0022
Ultrasound-Assisted Extraction of Cannabinoids from Cannabis Sativa L.
L. Csoka
University of Sopron, Institute of Wood Based Products nadTechnologies, SOPRON, Hungary
CANNX18-0026
Virtual Rehabilitation Centre (VRC), an Integrative, Multi-Modal Follow-Up Tool for Chronic Pain
A. Boshyk1, S. Mosaad2, R. Marques3
1 Psychotherapist, Pain Management, Toronto, Canada; 2 Centres
for Pain Managment, Pain Managment, Toronto, Canada;
3 Centres for Pain Managment, Chiropractor, Toronto, Canada
CANNX18-0012
Cannabinoids in Dentistry Future Revolutionary Concept in Dental Treatments
V. Stahl
Cannabite Life Long/Euro Dent Belgium bvba, Dentistry, Mortsel, Belgium
CANNX18-0027
Pros and Cons of Cloning Propagation and How to Shift to Seed Production
H. Less
Yarok-MedTech Ltd., Co-Founder, Orot, Israel